Survival times of patients with Menetrier's disease and risk of gastric cancer

- Almazar, Ann E., Penfield, Joshua D., Saito, Yuri A., Talley, Nicholas J.

The natural history of chronic unexplained gastrointestinal disorders and gastroesophageal reflux during 20 Years: A US population-based study

- Choung, Rok Seon, Saito, Yuri A., Schleck, Cathy D., Harmsen, William S., Zinsmeister, Alan R., Murray, Joseph A., Talley, Nicholas J.

Comparison of Lactase Variant MCM6-13910 C>T Testing and Self-report of Dairy Sensitivity in Patients with Irritable Bowel Syndrome

- Almazar, Almazar E., Chang, Joseph Y., Larson, Joseph J., Atkinson, Elizabeth J., Locke, G. Richard, Talley, Nicholas J., Saito, Yuri A.

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

- Saito, Yuri A., Almazar, Ann E., Tilkes, Katherine E., Choung, Rok Seon, Van Norstrand, Michael D., Schleck, Cathy D., Zinsmeister, Alan R., Talley, Nicholas J.

Celiac disease is uncommon in irritable bowel syndrome in the USA

- Almazar, Ann E., Talley, Nicholas J., Larson, Joseph J., Atkinson, Elizabeth J., Murray, Joseph A., Saito, Yuri A.

Early infections and the risk of irritable bowel syndrome: a case-control study

- Krajicek, Edward J., Almazar, Ann E., Larson, Joseph J., Atkinson, Elizabeth J., Talley, Nicholas J., Saito, Yuri A.

Effects of amitriptyline and escitalopram on sleep and mood in patients with functional dyspepsia

- Herrick, Linda M., Camilleri, Michael, Schleck, Cathy D., Zinsmeister, Alan R., Saito, Yuri A., Talley, Nicholas J.

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and response to antidepressant treatment in functional dyspepsia: a study from the functional dyspepsia treatment trial

- Saito, Yuri A., Locke, G. Richard, Moayyedi, Paul, Herrick, Linda M., Szarka, Lawrence A., Camilleri, Michael, Hamilton, Frank A., Schleck, Cathy D., Tilkes, Katherine E., Zinsmeister, Alan R., Talley, Nicholas J., Almazar, Ann E., Bouras, Ernest P., Howden, Colin W., Lacy, Brian E., Dibaise, John K., Prather, Charlene M., Abraham, Bincy P., El-Serag, Hashem B.

Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study

- Talley, Nicholas J., Locke, G. Richard, El-Serag, Hashem B., Moayyedi, Paul, Herrick, Linda M., Szarka, Lawrence A., Camilleri, Michael, Hamilton, Frank A., Schleck, Cathy D., Tilkes, Katherine E., Zinsmeister, Alan R., Saito, Yuri A., Almazar, Ann E., Bouras, Ernest P., Howden, Colin W., Lacy, Brian E., DiBaise, John K., Prather, Charlene M., Abraham, Bincy P.

Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome

- Holliday, Elizabeth G., Attia, John, Almazar, Ann E., Saito, Yuri A., Scott, Rodney J., Talley, Nicholas J., Hancock, Stephen, Koloski, Natasha, McEvoy, Mark, Peel, Roseanne, D'Amato, Mauro, Agréus, Lars, Nyhlin, Henry, Andreasson, Anna

Loss-of-function of the voltage-gated sodium channel Na_V1.5 (channelopathies) in patients with irritable bowel syndrome

- Beyder, Arthur, Mazzone, Amelia, Lindberg, Greger, Karling, Pontus, Ohlsson, Bodil, Gazouli, Maria, Nardone, Gerardo, Cuomo, Rosario, Usai-Satta, Paolo, Galeazzi, Francesca, Neri, Matteo, Portincasa, Piero, Strege, Peter R., Bellini, Massimo, Barbara, Giovanni, Camilleri, Michael, Locke III, G. Richard, Talley, Nicholas J., D'Amato, Mauro, Ackerman, Michael J., Farrugia, Gianrico, Tester, David J., Saito, Yuri A., Bernard, Cheryl E., Enders, Felicty T., Ek, Weronica E., Schmidt, Peter T., Dlugosz, Aldona

The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene–environment interactions in Irritable Bowel Syndrome (IBS)

- Saito, Yuri A., Larson, Joseph J., Atkinson, Elizabeth J., Ryu, Euijung, Almazar, Ann E., Peterson, Gloria M., Talley, Nicholas J.